Evidence map›Paper›PMID 41683710›Full record

ArticleInternational journal of molecular sciences2026

bFGF Oligomeric Stability Drives Functional Performance in Human Pluripotent Stem Cells.

Dylan E Iannitelli, Naryeong Kim, Luladey Ayalew, Qiang Wu, Xinzheng Victor Guo, Kyle Spitler, Manasa P Srikanth, Julien Camperi

Abstract read
In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Dylan E IannitelliCell Therapy Engineering and Development, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.ORCID 0000-0002-7654-9433
Naryeong KimCell Therapy Engineering and Development, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.
Luladey AyalewCell Therapy Engineering and Development, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.
Qiang WuCell Therapy Engineering and Development, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.
Xinzheng Victor GuoCell Therapy Engineering and Development, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.ORCID 0000-0003-0499-9870
Kyle SpitlerProtein Analytical Chemistry, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.
Manasa P SrikanthCell Therapy Engineering and Development, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.ORCID 0000-0002-9831-4141
Julien CamperiCell Therapy Engineering and Development, Genentech, 1 DNA Way, South San Francisco, CA 94080, USA.ORCID 0000-0002-4020-2278

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Basic fibroblast growth factor (bFGF) and Transforming growth factor-beta (TGF-β) are key regulators of human pluripotent stem cell (hPSC) maintenance, supporting pluripotency and self-renewal. bFGF is particularly critical for sustaining the undifferentiated state and is commonly supplied through feeder-derived conditioned media. Similarly, TGF-β promotes hPSC expansion by modulating signaling pathways and contributing to a supportive stem cell niche. In this study, we investigated how the quality and variability of these growth factors influence hPSC culture performance. To address this, we developed and applied multiple physicochemical characterization methods-including size exclusion and reverse-phase chromatography-to assess growth factor purity and identify impurities across different material sources. Our findings show that certain post-translational modifications in TGF-β (e.g., oxidized variants) did not measurably affect hPSC culture. However, high temperature-dependent instability of bFGF preparations significantly altered hPSC morphology and growth. These findings underscore the need for improved quality control of growth factor components in culture media to ensure consistent hPSC maintenance, thus decreasing variability across experiments. This study highlights the value of correlating analytical physicochemical data with process performance, thereby advancing material understanding, enabling more efficient process development, and facilitating the identification of critical material attributes that affect the quality of cell therapy products.

Indexed as

Fibroblast Growth Factor 2Pluripotent Stem CellsCell Culture TechniquesCell DifferentiationCell ProliferationHumansProtein Processing, Post-TranslationalProtein StabilityTransforming Growth Factor betaFibroblast Growth Factor 2Transforming Growth Factor betaaggregatesgrowth factor proteinshuman PSCsphysicochemical/functionality characterization

Identifiers

PMID41683710
PMCPMC12898039

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.